Intestinal Microbiota After PPI Treatment

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 6, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

February 1, 2027

Conditions
Proton Pump InhibitorsHuman Gastrointestinal TractGastroesophageal Reflux Disease
Interventions
OTHER

study of microbiota

"* Drug: Esomeprazole, a proton pump inhibitor commonly used in pediatric gastroenterology.~* Administration: Oral, once daily, 30 minutes before meals.~* Dosage: Personalized dosing according to body weight, with an average of approximately 0.6 mg/kg/day.~* Treatment duration: Minimum 45 days, maximum 60 days.~* Comparator: None. This is a within-subject design; each participant serves as their own control with baseline samples (t0) compared to follow-up (t1-t2).~* Monitoring: Adherence to therapy and sample collection timeline will be verified during scheduled clinical follow-up."

Trial Locations (1)

70100

Pediatria Trambusti, Bari

All Listed Sponsors
lead

University of Bari

OTHER